December 17, 2025 06:25 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Goa nightclub fire horror: Luthra brothers brought back to India from Thailand, arrested | Messi chaos costs minister his job: Aroop Biswas resigns after Salt Lake Stadium fiasco | Bengal SIR draft list out: Around 58 lakh voters’ names dropped | Relief for Sonia, Rahul Gandhi as Delhi court refuses to act on ED chargesheet in National Herald case | Centre moves to replace MGNREGA with 'G Ram G', sets stage for winter session showdown | Messi surrounded by VIPs, fans rage: Five held in stadium vandalism case | 'Messi was uncomfortable, lost his cool!': Ex-India footballer reveals what really happened at chaotic Kolkata stadium | PM Modi embarks on historic three-nation visit to Jordan, Ethiopia, and Oman | Caught in Thailand! Fugitive Goa nightclub owners detained after deadly fire kills 25 | After Putin’s blockbuster Delhi visit, Modi set to host German Chancellor Friedrich Merz in January
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.